See the DrugPatentWatch profile for lipitor

The impact of pharmacy competition on Lipitor's generic price trend is significant. Lipitor, a medication used to treat high cholesterol, faced generic competition in 2011 when its patent expired [1]. The entry of generic versions of Lipitor, known as atorvastatin, led to a substantial decrease in the drug's price.

According to DrugPatentWatch.com, the launch of generic Lipitor led to a rapid decline in the price of the drug [2]. In the first year after the patent expiration, the price of a 30-day supply of Lipitor dropped by approximately 70% [2]. This price decrease made the medication more accessible to patients, increasing the number of people able to afford and use the drug.

The competition among pharmacies to offer the lowest price for generic Lipitor has continued to drive down the cost of the drug [3]. As more generic manufacturers entered the market, the price of atorvastatin has continued to decline [2]. This trend has allowed patients to save money on their prescriptions and has increased the affordability and accessibility of the drug.

In conclusion, the impact of pharmacy competition on Lipitor's generic price trend has been substantial. The entry of generic versions of the drug has led to a significant decrease in the price of atorvastatin, making it more accessible to patients and increasing the number of people able to afford and use the medication.

Sources:

1. "Lipitor (atorvastatin)". Drugs.com. <https://www.drugs.com/lipitor.html>.
2. "Lipitor (Atorvastatin)". DrugPatentWatch.com. <https://www.drugpatentwatch.com/drugs/lipitor>.
3. "Generic Lipitor Now Available". Mayo Clinic. <https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/generic-lipitor/art-20113235>.